Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación
Capítulo o parte de un libro (BookPart)
Nutraceuticals and oxidative stress
Several studies have found a link between oxidative stress and a variety of
noncommunicable diseases including diabetes, obesity, aging, Down syndrome, cancers, cardiovascular, and neurodegenerative diseases. All these pathologies are aided
by oxidative stress, which is caused by the excessive production of free radicals or
insufficient elimination of free radicals. To avoid, reduce, or eliminate this imbalance
favoring prooxidants in organs and cells, one of the healthier and promising approaches is to use antioxidant compounds like nutraceuticals, which can scavenge the
excessive free radicals and restore the balance. Nutraceuticals are dietary compounds
that include dietary fibers, prebiotics, probiotics, polyunsaturated fatty acids, vitamins, minerals, polyphenols, and spices. Some of them have antioxidant activity,
which can react with the free electron available in the outer layer of free radicals to
make the unstable compounds more stable while avoiding free radicals’ proliferation
and the induced damage to the different metabolisms that occur in the human body
because of oxidative stress. Thus, each nutraceutical class performs specific functions
in managing the onset of oxidative stress. Therefore, the purpose of this chapter is to
sort out the mechanisms by which different classes of nutraceuticals can have beneficial effects on oxidative stress and related pathologies via their biological properties.
However, it also observes that the efficacy of nutraceutical compounds can only be
guaranteed if they can maintain their properties during production, preservation,
consumption, digestion, and use by the various targeted active sites. Thus, it shows
that the concepts of bioavailability and bio-accessibility are key factors for the effectiveness of nutraceuticals on oxidative stress when consumed by humans., Agencia Estatal de Investigación | Ref. RYC-2017-22891, Xunta de Galicia | Ref. ED431F 2020/12, Xunta de Galicia | Ref. ED481B-2021/152, CYTED—AQUACIBUS | Ref. P317RT0003